Luciana Irtelli
-
- Cancer Treatment and Pharmacology 4
- Lung Cancer Research Studies 4
- Colorectal Cancer Treatments and Studies 3
-
- Cancer Genomics and Diagnostics 3
-
- Lung Cancer Treatments and Mutations 7
- Lung Cancer Diagnosis and Treatment 3
-
- Neuroendocrine Tumor Research Advances 2
-
- Estrogen and related hormone effects 2
- Co-authors
- Clara NatoliLara FelicioniFiamma ButtittaAntonio MarchettiStefano IacobelliFrancesco CognettiMichele De TursiAlain Gelibter
- Partner nations
- ItalyMalaysiaUnited Kingdom
In The Last Decade
Luciana Irtelli
15 papers receiving 261 citations
Peers
Comparison fields: 5 of 51
- Oncology 173
- Cancer Research 67
- Pulmonary and Respiratory Medicine 116
- Neurology 33
- Epidemiology 61
Countries citing papers authored by Luciana Irtelli
This map shows the geographic impact of Luciana Irtelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luciana Irtelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luciana Irtelli more than expected).
Fields of papers citing papers by Luciana Irtelli
This network shows the impact of papers produced by Luciana Irtelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luciana Irtelli. The network helps show where Luciana Irtelli may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Luciana Irtelli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 31 | |
| 2 | 2020 | 9 | |
| 3 | 2020 | 35 | |
| 4 | 2017 | 5 | |
| 5 | 2017 | 11 | |
| 6 | 2012 | 51 | |
| 7 | 2009 | 84 | |
| 8 | A phase II study of neoadjuvant chemotherapy with cisplatin epirubicin and VP-16 for stage III unresectable non-small cell lung cancer. | 1998 | 1 |
| 9 | 1997 | 6 | |
| 10 | 1997 | 1 | |
| 11 | 1996 | 6 | |
| 12 | A phase I study of 5-day continuous venous infusion of carboplatin at circadian rhythm-modulated rate compared with constant rate. | 1996 | 3 |
| 13 | Chronomodulated infusion of 5-fluorouracil, folinic acid and carboplatin in colorectal cancer: a pilot study. | 1996 | 4 |
| 14 | 1995 | 14 | |
| 15 | 1992 | 2 |
About Luciana Irtelli
Luciana Irtelli is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 15 papers that have together received 263 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), Cancer Treatment and Pharmacology (4 papers), Lung Cancer Research Studies (4 papers), Lung Cancer Diagnosis and Treatment (3 papers), Cancer Genomics and Diagnostics (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Neuroendocrine Tumor Research Advances (2 papers) and Estrogen and related hormone effects (2 papers). The work is most often cited by research in Oncology (173 citations), Cancer Research (67 citations) and Pulmonary and Respiratory Medicine (116 citations). Luciana Irtelli has collaborated with scholars based in Italy, Malaysia and United Kingdom. Frequent co-authors include Clara Natoli, Lara Felicioni, Fiamma Buttitta, Antonio Marchetti, Stefano Iacobelli, Francesco Cognetti, Michele De Tursi, Alain Gelibter, Michèle Milella and Carmen Nuzzo. Their work appears in journals such as Annals of Oncology, European Journal of Cancer and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.